Compass Therapeutics Inc. - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
CMPX Nasdaq 8731 https://www.compasstherapeutics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Compass Therapeutics Inc.

Compass Therapeutics Announces First Patient Dosed in the Phase 1 Study of CTX-8371 in Patients with Solid Tumors - Apr 16th, 2024 12:00 pm
Compass Therapeutics Announces Poster Presentations at the Cholangiocarcinoma Foundation 2024 Annual Conference - Apr 12th, 2024 12:00 pm
Compass Therapeutics to Participate in the Stifel Targeted Oncology Days - Apr 10th, 2024 12:00 pm
Compass Therapeutics Presents Data Demonstrating Elimination of MHC Class I Negative Tumors in In Vivo Models at the 2024 American Association for Cancer Research (AACR) Annual Meeting - Apr 9th, 2024 4:00 pm
Compass Therapeutics Reports 2023 Financial Results and Provides Corporate Update - Mar 21st, 2024 1:00 pm
Compass Therapeutics to Participate in the Leerink Partners Global Biopharma Conference - Feb 29th, 2024 1:00 pm
Compass Therapeutics Announces Publication of CTX-8371 Preclinical Data in OncoImmunology, its Bispecific Antibody Checkpoint Inhibitor, now Advancing to First-in-Human Clinical Trial - Feb 28th, 2024 1:00 pm
Compass Therapeutics Provides Corporate Update - Jan 5th, 2024 1:00 pm
Compass Therapeutics Insider Ups Holding During Year - Dec 12th, 2023 12:27 pm
Compass Therapeutics Inc (CMPX) Reports Q3 2023 Financial Results and Corporate Developments - Nov 9th, 2023 1:17 pm
Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update - Nov 9th, 2023 12:30 pm
Compass Therapeutics to Participate in Upcoming Investor Events - Nov 7th, 2023 1:00 pm
Compass Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update - Aug 3rd, 2023 12:00 pm
Compass Therapeutics to be Added to the Russell 2000® and Russell 3000® Indexes - Jun 22nd, 2023 8:05 pm
Compass Therapeutics Reports First Quarter Financial Results and Provides Corporate Update - May 4th, 2023 12:30 pm
Compass Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ - Apr 26th, 2023 12:30 pm